Non Small Cell Lung Cancer
Showing NaN - NaN of 39
PET-CT Predicting Segement Specific Lymph Nodes Metastasis
Recruiting
- Non Small Cell Lung Cancer
- +2 more
-
Shanghai, ChinaShanghai Cancer Center
Jul 23, 2023
Non Small Cell Lung Cancer Trial in China (TQB2450 injection + Chemotherapy, TQB2450 injection + Anlotinib Hydrochloride
Recruiting
- Non Small Cell Lung Cancer
- TQB2450 injection + Chemotherapy
- TQB2450 injection + Anlotinib Hydrochloride Capsule
-
Beijing, Beijing, China
- +9 more
Jun 27, 2023
Non Small Cell Lung Cancer Trial in Worldwide (Telisotuzumab Vedotin, Docetaxel)
Recruiting
- Non Small Cell Lung Cancer
- Telisotuzumab Vedotin
- Docetaxel
-
Los Angeles, California
- +212 more
Jan 26, 2023
Non Small Cell Lung Cancer Trial in Shanghai (CS1001 mAb, CS1001 )
Active, not recruiting
- Non Small Cell Lung Cancer
- CS1001 monoclonal antibody
- CS1001 placebo
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital
Nov 8, 2022
Non Small Cell Lung Cancer Trial in Worldwide (Telisotuzumab Vedotin)
Not yet recruiting
- Non Small Cell Lung Cancer
- Telisotuzumab Vedotin
-
Clayton, Victoria, Australia
- +54 more
Aug 23, 2022
Resectable Non-Small Cell Lung Cancer Stages IIB-IIIB
Recruiting
- Non Small Cell Lung Cancer
- anti-PD-1 or anti-PD-L1
- +2 more
-
Shanghai, ChinaOncology Department, Shanghai Chest Hospital
Jul 26, 2022
Non Small Cell Lung Cancer Trial in Shanghai (HS-10241)
Recruiting
- Non Small Cell Lung Cancer
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
Jun 19, 2022
Non Small Cell Lung Cancer Trial in Worldwide (Nivolumab, Cisplatin, Vinorelbine)
Active, not recruiting
- Non Small Cell Lung Cancer
- Nivolumab
- +8 more
-
Glendale, Arizona
- +135 more
Feb 28, 2022
Non Small Cell Lung Cancer Trial in China (Tislelizumab, Cisplatin injection, Paclitaxel injection)
Recruiting
- Non Small Cell Lung Cancer
- Tislelizumab
- +5 more
-
Hefei, Anhui, China
- +47 more
Jan 24, 2022
Non Small Cell Lung Cancer Trial in China (Chidamide, Envafolimab)
Recruiting
- Non Small Cell Lung Cancer
-
Hefei, Anhui, China
- +11 more
Jan 17, 2022
Non Small Cell Lung Cancer Trial in Shanghai (Trametinib, Anlotinib)
Recruiting
- Non Small Cell Lung Cancer
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
Jan 16, 2022
Sarcopenia and Nutritional Status in Early-stage Non-small Cell
Not yet recruiting
- Sarcopenia
- +2 more
- Inbody 570
- +2 more
-
Shanghai, Shanghai, ChinaHuadong hospital, Fudan University
Jan 27, 2022
Non Small Cell Lung Cancer Trial in Shanghai (RC48)
Active, not recruiting
- Non Small Cell Lung Cancer
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital
Jan 26, 2022
Non Small Cell Lung Cancer Trial in Shanghai (Tislelizumab, Carboplatin, Pemetrexed)
Recruiting
- Non Small Cell Lung Cancer
- Tislelizumab
- +4 more
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
Nov 19, 2021
Non Small Cell Lung Cancer Trial in China (TQB2450 injection, Anlotinib Hydrochloride Capsules, Pembrolizumab injection)
Recruiting
- Non Small Cell Lung Cancer
- TQB2450 injection
- +3 more
-
Beijing, Beijing, China
- +16 more
Aug 18, 2021
Identify Prognostic Biomarkers of Lung Cancer
Recruiting
- Lung Cancer
- +3 more
-
Shanghai, ChinaRenji Hospital, Shanghai Jiaotong University school of medicine
Aug 14, 2021
Non Small Cell Lung Cancer Trial in Shanghai (AB-106)
Recruiting
- Non Small Cell Lung Cancer
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital
Jun 17, 2021
Non Small Cell Lung Cancer, ROS1 Proto Oncogene, Crizotinib Trial in Worldwide (Crizotinib)
Completed
- Non Small Cell Lung Cancer
- +2 more
-
Hefei, Anhui, China
- +43 more
Feb 3, 2021
Non Small Cell Lung Cancer Trial in Shanghai (Durvalumab Anlotinib Carboplatin Nab-paclitaxel)
Recruiting
- Non Small Cell Lung Cancer
- Durvalumab Anlotinib Carboplatin Nab-paclitaxel
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital
Feb 17, 2021
Non Small Cell Lung Cancer Trial in China (Carboplatin, Pemetrexed or Nab-paclitaxel, PD-1 antibody)
Recruiting
- Non Small Cell Lung Cancer
- Carboplatin
- +2 more
-
Lanzhou, Gansu, China
- +7 more
Feb 18, 2021
Inactivated Trivalent Influenza Vaccine on NSCLC Patients
Not yet recruiting
- Non Small Cell Lung Cancer
- Influenza Vaccine
- PD-1/PD-L1 inhibitors
- Inactivated trivalent influenza vaccine
-
Hong Kong, Hong Kong, China
- +1 more
Apr 20, 2020
Non Small Cell Lung Cancer Trial in Shanghai (radiochemo 1, radiochemo 2, radiochemo 3)
Completed
- Non Small Cell Lung Cancer
- radiochemotherapy 1
- +6 more
-
Shanghai, Chinathe Ethic Committee of Shanghai General Hospital
May 1, 2019
Non Small Cell Lung Cancer Trial in Shanghai (Mitochondria-targeted System Therapy Combined With Radiofrequency Ablation,
Recruiting
- Non Small Cell Lung Cancer
- Mitochondria-targeted System Therapy Combined With Radiofrequency Ablation
- Surgery
-
Shanghai, Shanghai, ChinaShanghai 10th People's Hospital
Feb 18, 2019
Non Small Cell Lung Cancer, Breast Cancer Trial in China (YPEG-rhG-CSF, 20µg/kg, single s.c. at 48hrs after chemo for each
Completed
- Non Small Cell Lung Cancer
- Breast Cancer
- YPEG-rhG-CSF, 20μg/kg, single s.c. at 48hrs after chemotherapy for each experimental cycle
- +3 more
-
Zhangzhou, Fujian, China
- +11 more
Jul 15, 2018